Novavax, Inc. (NVAX): Price and Financial Metrics

NVAX POWR Grades

• NVAX scores best on the Growth dimension, with a Growth rank ahead of 98.35% of US stocks.
• The strongest trend for NVAX is in Growth, which has been heading down over the past 179 days.
• NVAX's current lowest rank is in the Sentiment metric (where it is better than 0.34% of US stocks).

NVAX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for NVAX is -3.26 -- better than only 3.52% of US stocks.
• Of note is the ratio of NOVAVAX INC's sales and general administrative expense to its total operating expenses; just 6.55% of US stocks have a lower such ratio.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -8.12 for NOVAVAX INC; that's greater than it is for merely 2.43% of US stocks.
• Stocks that are quantitatively similar to NVAX, based on their financial statements, market capitalization, and price volatility, are GRNA, HGEN, ATHX, KZIA, and CNCE.
• NVAX's SEC filings can be seen here. And to visit NOVAVAX INC's official web site, go to www.novavax.com.

NVAX Valuation Summary

• In comparison to the median Healthcare stock, NVAX's price/sales ratio is 65% lower, now standing at 0.7.
• NVAX's price/earnings ratio has moved up 3.5 over the prior 243 months.

Below are key valuation metrics over time for NVAX.

NVAX Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 58.8%.
• Its 3 year revenue growth rate is now at 4802.79%.
• Its 2 year cash and equivalents growth rate is now at 745.36%.

NVAX's revenue has moved up $1,828,011,000 over the prior 33 months.

The table below shows NVAX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	1,846.673	-640.529	-1,321.974
2022-06-30	1,290.94	-743.964	-1,475.792
2022-03-31	1,403.032	-428.649	-1,317.624
2021-12-31	1,146.29	322.946	-1,743.751
2021-09-30	1,203.749	536.786	-1,075.031
2021-06-30	1,181.929	672.432	-949.91

NVAX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVAX has a Quality Grade of C, ranking ahead of 58.82% of graded US stocks.
• NVAX's asset turnover comes in at 0.6 -- ranking 60th of 680 Pharmaceutical Products stocks.
• GTHX, SRRA, and OPK are the stocks whose asset turnover ratios are most correlated with NVAX.

The table below shows NVAX's key quality metrics over time.